“showed a trend”

Ischemic heart disease and dementia also showed a trend toward predicted the ED delirium (OR, 2.20; 95% CI, 0.93–5.20; P = 0.07 and OR, 5.54; 95% CI, 0.91–33.53; P = 0.06, respectively). 4.

II–IV), expression of miR-146a was higher in patients with severe GvHD (grade II–IV) compared to patients with no/mild aGvHD (grade 0–I) ( p = 0.003), while expression of miR-155 showed a trend to higher expression in patients with severe aGvHD (stage II–IV) ( p = 0.07).

In line with these findings, individuals with high HbA1c levels (≥7.5%) showed a trend for higher weight loss (p = 0.07; Supplemental Figure S3F ).

We found a trend towards an increase in the TNFR1 + classical monocyte cell population [Ctl: 1.87% (1.21–2.52) and IS: 2.54% (2.07–4.27), U = 51.5, p = 0.07] in ischemic stroke patients compared to controls, whereas the TNFR1 + intermediate cell population showed a trend towards a decrease [Ctl: 1.35% (0.44–2.52) and IS: 0.49% (0.13–1.04), U = 52, p = 0.07] ( Figure 3 f).

The abundance of Pseudomonas also showed a trend of positive correlation with the UCEIS (R = 0.44, p = 0.07).

Positive PD-L1 staining determined at a threshold of 1% showed a trend towards improved survival in the entire cohort (70.3% vs. 57.4%, p = 0.07) in univariate analysis ( Figure 2 ).

At 2 h post ingestion, CHQ showed a trend for increased S6K1 phosphorylation of P = 0.07 compared to baseline (Fig. 4 B). 4E-BP1 (Thr37/46) phosphorylation was significantly increased ( P < 0.05) at 1 h post ingestion in both groups compared to baseline.

These post-hoc comparisons also showed a trend that Remember trials were associated with increased frequency of subsequent information-seeking relative to Unfamiliar trials, p = 0.07.

In analyses of baseline metabolite factors with change in pVO 2 between baseline and three months , no factor was significant nominally nor after FDR adjustment for multiple comparisons (Additional file 2 : Table S1), although factor 8 showed a trend for significance (nominal p = 0.07) for baseline levels associated with change in pVO 2 .

Neutrophils showed a trend to increase in ELA groups (P < 0.07) ( Figure 10C ).

Analysis of sp3 VSL showed a trend of the triple interaction due to extender, temperature, and time ( p = 0.07), revealing consistent effects with that described for VSL in the global sperm population. 3.2.2.

NETs’ levels inversely correlated with CD8 + T-cell density ( R = –0.33, p = 0.025) and showed a trend toward positive correlation with CAFs ( R = 0.27, p = 0.07).

The NC group showed a trend toward the lowest relative abundance of Pseudomonadota on d 20 ( P = 0.07).

It showed a trend toward worse cardiac outcomes in the diabetic subgroup after liraglutide administration (HR = 1.54, p = 0.07), while there was no significant difference in the number of deaths or re-hospitalizations for HF in individuals without diabetes between the liraglutide group and the placebo group (HR = 1.02, p = 0.94) [ 147 ].

Results: HIIE and MICE showed a trend to decrease ghrelin levels immediately post-exercise (-14.1 ± 21.6% and −9.6 ± 23.8%, respectively, p = 0.07) and decreased 1h post-exercise (-12.7 ± 31.8% and −13.8 ± 21.7%, respectively, p < 0.05).

Although not reaching significance, patients who converted showed a trend towards lower alpha rhythmic power in F3 (converters: 22.79 ± 1.20; non-converters: 27.32 ± 1.56; p = .07), O1 (converters: 35.21 ± 2.56; non-converters: 41.86 ± 2.19, p = .085) and O2 (converters: 35.76 ± 2.60; non-converters: 42.82 ± 2.23, p = .06).

4.7 months, p < 0.01) and showed a trend toward longer OS (17.1 vs. 8.2 months, p = 0.07) compared to those without irAEs.

Size and percentage of T2LIA showed a trend towards association with survival ( p = 0.07 and 0.05, respectively).

42–44 In a randomised controlled trial of 41 patients with AD, subcutaneous etanercept 50 mg once weekly showed a trend toward improvements in the Mini-Mental State Exam score (p = 0.07) and neuropsychiatric inventory (p=0.02). 45 In another study, 15 patients with AD were randomised to receive etanercept 25 mg twice a week (n=8) or adalimumab twice a month (n=7) subcutaneously.

Increased TILs showed a trend toward a significant association with better iDFS (HR 0.98, 95%CI 0.95–1.00, p = 0.07 for 10% increment; HR 0.38, 95%CI 0.14–1.02, p = 0.05 for TILs ≥ 30%).

After multiple corrections, the post hoc test showed a trend for an increased R2 area at all interstimulus intervals (R2: 3–5 s: t (24) = 2.1; p = 0.07; 8–10 s: t (24) = 2.2; p = 0.06; 15–17 s: t (24) = 2.3; p = 0.05).

However, in MOLM-14 cells, shPSMD3 showed a trend for reduced NF-κB transcriptional activity, which was not further reduced by quizartinib therapy ( Figure 4 B; p = 0.07).

All these external synchronizers changed significantly with confinement (p < 0.001), except for night fasting duration that only showed a trend (p = 0.07).

Although underpowered to investigate the relationship, the A 1c -Derived Average Glucose (ADAG) study showed a trend ( P < 0.07) toward higher HbA 1c in people of African background, independent of chronic glycemia, which was measured using a combination of continuous glucose monitoring and frequent capillary glucose testing ( 17 ).

The same was true for hiPSC line CaSR, except for the fact that Perimeter only showed a trend towards statistical significance ( p = 0.07).